<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about QDEL</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Sat, 18 May 2013 20:00:33 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=QDEL" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/earnings-preview-covidien-analyst-blog-cm209947">
      <guid isPermaLink="false">209947</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C5KA7XZMu9g/earnings-preview-covidien-analyst-blog-cm209947</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Earnings Preview: Covidien - Analyst Blog</title>
      <description>Covidien  plc.  (  COV  ) is set to report its first-quarter fiscal 2013 results, before the market opens, on Friday, Jan 25. Let's see how things are shaping up prior to the announcement.  In&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/C5KA7XZMu9g" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 23 Jan 2013 21:14:23 Z</pubDate>
      <a10:updated>2013-01-23T17:19:39Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>HRC</nasdaq:tickers>
      <nasdaq:tickers>NUVA</nasdaq:tickers>
      <nasdaq:tickers>QDEL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/earnings-preview-covidien-analyst-blog-cm209947</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/surmodics-recruits-new-finance-head-analyst-blog-cm202684">
      <guid isPermaLink="false">202684</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2RtwWS9yuTk/surmodics-recruits-new-finance-head-analyst-blog-cm202684</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>SurModics Recruits New Finance Head - Analyst Blog</title>
      <description>SurModics, Inc.  (  SRDX  ), a provider of surface modification and drug delivery technologies to the healthcare industry, recently revealed that it has appointed Andy LaFrence as the chief&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/2RtwWS9yuTk" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 28 Dec 2012 18:20:01 Z</pubDate>
      <a10:updated>2012-12-28T15:43:52Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>COV</nasdaq:tickers>
      <nasdaq:tickers>QDEL</nasdaq:tickers>
      <nasdaq:tickers>SRDX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/surmodics-recruits-new-finance-head-analyst-blog-cm202684</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/ce-mark-for-quidel-rsvhmpv-test-analyst-blog-cm127088">
      <guid isPermaLink="false">127088</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WKauZcQGVeU/ce-mark-for-quidel-rsvhmpv-test-analyst-blog-cm127088</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>CE Mark for Quidel RSV+hMPV Test - Analyst Blog</title>
      <description>Leading diagnostic test solutions provider   Quidel Corporation   (   QDEL   ) has won the European CE Mark for its new virus test dubbed the "Quidel Molecular RSV + hMPV Assay"&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/WKauZcQGVeU" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 14 Mar 2012 03:14:01 Z</pubDate>
      <a10:updated>2012-03-14T00:22:31Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ALR</nasdaq:tickers>
      <nasdaq:tickers>QDEL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/ce-mark-for-quidel-rsvhmpv-test-analyst-blog-cm127088</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/quidel-beats-estimates-analyst-blog-cm124651">
      <guid isPermaLink="false">124651</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GkW5SCWfuZQ/quidel-beats-estimates-analyst-blog-cm124651</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Quidel Beats Estimates - Analyst Blog</title>
      <description>Leading diagnostic test solutions provider   Quidel Corporation   's (   QDEL   ) fourth-quarter fiscal 2011 adjusted earnings (excluding one-time items other than stock-based compensation&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/GkW5SCWfuZQ" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 02 Mar 2012 19:45:01 Z</pubDate>
      <a10:updated>2012-03-02T16:55:17Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ALR</nasdaq:tickers>
      <nasdaq:tickers>QDEL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/quidel-beats-estimates-analyst-blog-cm124651</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/fda-nod-for-quidels-hmpv-test-analyst-blog-cm111111">
      <guid isPermaLink="false">111111</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1cRJJCDDgbg/fda-nod-for-quidels-hmpv-test-analyst-blog-cm111111</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>FDA Nod for Quidel's hMPV Test - Analyst Blog</title>
      <description>Leading diagnostic test solutions provider   Quidel Corporation   (   QDEL"&amp;gt;QDEL   ) has won the approval of the U.S. Food and Drug Administration ("FDA") for its new&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/1cRJJCDDgbg" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 28 Dec 2011 03:58:01 Z</pubDate>
      <a10:updated>2011-12-28T01:02:18Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ALR</nasdaq:tickers>
      <nasdaq:tickers>QDEL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/fda-nod-for-quidels-hmpv-test-analyst-blog-cm111111</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/ce-mark-for-quidels-strep-a-test-analyst-blog-cm107692">
      <guid isPermaLink="false">107692</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yPiL8BWZ0NE/ce-mark-for-quidels-strep-a-test-analyst-blog-cm107692</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>CE Mark for Quidel's Strep A Test - Analyst Blog</title>
      <description>Leading diagnostic test solutions provider   Quidel Corporation   (   QDEL   ) recently won the European CE Mark for its Sofia Streptococcus A ("Strep A") test for use with its Sofia&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/yPiL8BWZ0NE" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 08 Dec 2011 21:30:01 Z</pubDate>
      <a10:updated>2011-12-08T18:02:44Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ALR</nasdaq:tickers>
      <nasdaq:tickers>QDEL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/ce-mark-for-quidels-strep-a-test-analyst-blog-cm107692</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/centenarians-health-services-stocks-with-hedge-fund-buying-cm87111">
      <guid isPermaLink="false">87111</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IbmiHzjMUHY/centenarians-health-services-stocks-with-hedge-fund-buying-cm87111</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Centenarians: Health Services Stocks With Hedge Fund Buying</title>
      <description>( List compiled by Becca Lipman. Data sourced from Finviz. )  Our life expectancy is a sensitive piece of guesswork, and an important factor for the future sustainability of healthcare. Our&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/IbmiHzjMUHY" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 26 Jul 2011 01:34:30 Z</pubDate>
      <a10:updated>2011-07-25T21:34:32Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>AMRN</nasdaq:tickers>
      <nasdaq:tickers>DGX</nasdaq:tickers>
      <nasdaq:tickers>ECYT</nasdaq:tickers>
      <nasdaq:tickers>EPOC</nasdaq:tickers>
      <nasdaq:tickers>HS</nasdaq:tickers>
      <nasdaq:tickers>IRWD</nasdaq:tickers>
      <nasdaq:tickers>OPK</nasdaq:tickers>
      <nasdaq:tickers>QCOR</nasdaq:tickers>
      <nasdaq:tickers>QDEL</nasdaq:tickers>
      <nasdaq:tickers>VRUS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/centenarians-health-services-stocks-with-hedge-fund-buying-cm87111</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/4-stocks-seeing-strong-buy-volume-accumulation-insider-buying-cm61916">
      <guid isPermaLink="false">61916</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ub7aYVe1hOc/4-stocks-seeing-strong-buy-volume-accumulation-insider-buying-cm61916</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>4 Stocks Seeing Strong Buy Volume Accumulation, Insider Buying</title>
      <description>Compiled by Alexander Crawford:  It's often suggested that “volume precedes price”, and for that reason it's always helpful to look at the Money Flow Index (MFI), which is essentially a&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Ub7aYVe1hOc" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 14 Mar 2011 20:15:49 Z</pubDate>
      <a10:updated>2011-03-16T17:03:50Z</a10:updated>
      <author>Kapitall</author>
      <nasdaq:tickers>AEPI</nasdaq:tickers>
      <nasdaq:tickers>GLDD</nasdaq:tickers>
      <nasdaq:tickers>PBY</nasdaq:tickers>
      <nasdaq:tickers>QDEL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/4-stocks-seeing-strong-buy-volume-accumulation-insider-buying-cm61916</feedburner:origLink></item>
  </channel>
</rss>
